SRXH Stock Slides Premarket: Massive Share Issuance Plan Behind AI Crypto Pivot Sparks Dilution Concerns

The company recently said its EMJX AI hedging engine returned 5.69% in March, outperforming a 5% decline in the S&P 500.
SRXH stock has plunged 93% over the past year.
SRXH stock has plunged 93% over the past year. (Representative Image: Getty Images)
Profile Image
Deepti Sri·Stocktwits
Published Apr 15, 2026   |   5:02 AM EDT
Share
·
Add us onAdd us on Google
  • A fresh prospectus disclosed plans to issue up to 418 million shares in connection with the pending EMJ Crypto Technologies merger.
  • The acquisition supports SRx Health’s shift from a pet wellness business to an AI-driven digital-asset treasury platform.
  • The company said earlier that it plans to allocate up to 10% of cash flows to cryptocurrencies and precious metals.

Shares of SRx Health Solutions, Inc. (SRXH) slid 4% in premarket trading on Wednesday after a new prospectus revealed plans to issue up to 418 million shares as part of its merger with EMJ Crypto Technologies, raising dilution concerns as the company pushes deeper into its AI-powered digital-asset pivot.

On Tuesday, SRXH stock posted its second straight session of gains after closing nearly 1% higher at $0.136.

EMJ Crypto Acquisition Could Expand Share Count Over 20%

The prospectus relates to stock issuance tied to SRx Health’s proposed acquisition of EMJ Crypto Technologies and CCC Crypto Corp, along with associated intellectual property assets, including AI tools to predict outcomes from large datasets. The issuance could increase the number of outstanding shares by over 20%, the filing said.

The filing covers up to 418.3 million shares that may be issued through a combination of transaction consideration shares, exchangeable shares, and pre-funded warrants linked to the acquisition structure.

Digital Asset Pivot Starts Generating Early Gains

The deal comes amid SRx Health’s transformation from a pet-wellness-focused business to a digital-asset treasury platform driven by AI and quantitative models.

The company announced the definitive agreement to acquire EMJ Crypto Technologies in December as part of that strategy shift. Upon completion of the deal, EMJ Capital founder Eric Jackson is expected to become chairman and CEO of the combined company.

The acquisition also includes intellectual property assets, such as an algorithm designed to outperform Bitcoin and Ethereum by leveraging AI-driven analysis of trading volatility.

SRx Health said its hedging pool generated a 5.69% return in March using the EMJX AI engine, compared with a 5% decline in the S&P 500 over the same period. The company added that its board is “strongly considering” introducing a quarterly dividend policy based on a percentage of profits generated from its investment portfolio.

SRXH Expands Crypto Strategy Ahead Of EMJ Deal Close

In February, SRx Health authorized $18 million to deploy a “Gen2” treasury model designed to expand beyond single-asset digital strategies. The company reduced short exposure to Bitcoin and Ethereum to near zero across its $18 million cryptocurrency portfolio based on signals from internally developed models, while maintaining allocations to assets such as Solana and gold as part of its volatility-management framework.

SRx Health has also said it intends to allocate up to 10% of future cash flows to cryptocurrencies and precious metals as the EMJ Crypto deal nears completion.

How Do Retail Traders Feel About SRXH?

On Stocktwits, retail sentiment for SRXH has remained in the ‘bullish’ and ‘extremely bullish’ zones over the past three months amid ‘high’ 24-hour message volumes.

srxh ss.png
SRXH sentiment and message volume as of April 15 | Source: Stocktwits

One user said, “We’re on our way! Be strong! EMJX. Don’t get scared just as the fun begins.”

Another user said, “s4 Filed yesterday Merger intact should see a nice move Bottom penny. “

SRXH stock has plunged 93% over the past year.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: SpaceX IPO Watch: Is Starlink’s Margin Story Too Good To Be True? Analyst Says Its Profitability May Be Overstated

Follow on Google News
Read about our editorial guidelines and ethics policy